Latest UC Pharmacy College News

Newsletter – Spring 2025

The last week saw a new cohort of JLWCOP Pharm.D., M.S. and Ph.D. graduates sally forth into a world rocked almost daily by controversial policies from and practices by those in power. The disturbing national decline in standard vaccinations has resulted in resurgence of measles and other childhood maladies that had been eradicated in the U.S. decades ago. The dismantling of HHS vaccine research and production programs is a chilling development. Boomers (like I am) who thought they’d seen it all are shocked by much of it, so the younger generations that include our new graduates probably feel especially disoriented and vulnerable. 
Our graduates should nevertheless take heart for two reasons: First, there are inevitable corrections in healthcare approaches, the stock market, public opinion, etc. that will swing the pendulum back toward its familiar midpoint. Second, we will always need pharmacists and pharmaceutical scientists. Automation may temporarily decrease their numbers, for example, but those who pick up AI skills will survive and prosper. Even the most dogged critic knows that pharmaceutical research and development in the academic and private sectors are essential to living a long and quality life. The skill set for the pharmacist or pharmaceutical scientist will vary, however, so I advise our new graduates to stay ahead of the game by acquiring credentials in AI, public health, pharmacy advocacy, and other subjects in demand. In any walk of life or stressful situation, the people who are most versatile, adaptable and familiar with adversity come out on top.

Latest News

9

Where are the dupes for a $182 fan-favorite skincare product?

May 28, 2025

The University of Cincinnati's Kelly Dobos spoke with Business Insider about the expiration of the patent for SkinCeuticals' C E Ferulic vitamin C serum and the prospect of other brands making "dupes," or comparable products at a lower price.

Debug Query for this